| Primary |
| Hiv Infection |
55.7% |
| Product Used For Unknown Indication |
10.7% |
| Hepatitis B |
7.9% |
| Tuberculosis |
6.4% |
| Prophylaxis Against Hiv Infection |
6.3% |
| Prophylaxis |
2.9% |
| Hypertension |
1.6% |
| Chronic Hepatitis B |
1.3% |
| Contraception |
1.0% |
| Rash |
0.9% |
| Acquired Immunodeficiency Syndrome |
0.8% |
| Pulmonary Tuberculosis |
0.8% |
| Liver Transplant |
0.7% |
| Depression |
0.5% |
| Antifungal Prophylaxis |
0.5% |
| Diabetes Mellitus |
0.5% |
| Sciatica |
0.5% |
| Antiretroviral Therapy |
0.4% |
| Infection Prophylaxis |
0.4% |
| Neuropathy Peripheral |
0.4% |
|
| Abortion Spontaneous |
26.9% |
| Renal Failure Acute |
6.9% |
| Renal Failure |
6.5% |
| Nephropathy Toxic |
4.6% |
| Osteoporosis |
4.6% |
| Pregnancy |
4.6% |
| Death |
4.2% |
| Deep Vein Thrombosis |
4.2% |
| Malaria |
4.2% |
| Anaemia |
3.7% |
| Ankyloglossia Congenital |
3.7% |
| Neonatal Respiratory Distress Syndrome |
3.7% |
| Osteonecrosis |
3.7% |
| Stillbirth |
3.7% |
| Haemoglobin Decreased |
2.8% |
| Renal Tubular Acidosis |
2.8% |
| Hepatitis B |
2.3% |
| Nephritis |
2.3% |
| Platelet Count Decreased |
2.3% |
| Urinary Tract Infection |
2.3% |
|
| Secondary |
| Hiv Infection |
59.3% |
| Drug Exposure During Pregnancy |
6.6% |
| Drug Use For Unknown Indication |
5.8% |
| Antiretroviral Therapy |
5.1% |
| Product Used For Unknown Indication |
3.8% |
| Acquired Immunodeficiency Syndrome |
3.0% |
| Prophylaxis Against Hiv Infection |
2.9% |
| Prophylaxis |
1.5% |
| Antifungal Prophylaxis |
1.3% |
| Antiviral Treatment |
1.3% |
| Hiv Test Positive |
1.1% |
| Maternal Exposure Timing Unspecified |
1.1% |
| Tuberculosis |
1.1% |
| Diabetes Mellitus |
1.1% |
| Antiviral Prophylaxis |
0.9% |
| Maternal Exposure During Pregnancy |
0.9% |
| Hepatitis B |
0.9% |
| Pneumocystis Jiroveci Infection |
0.8% |
| Chest Discomfort |
0.7% |
| Diarrhoea |
0.7% |
|
| Vomiting |
12.3% |
| Abortion Spontaneous |
9.9% |
| Premature Baby |
7.5% |
| Progressive External Ophthalmoplegia |
7.2% |
| Drug Exposure During Pregnancy |
7.0% |
| Renal Failure Acute |
6.7% |
| Myocardial Infarction |
4.8% |
| Stillbirth |
4.6% |
| Immune Reconstitution Syndrome |
4.3% |
| Vanishing Bile Duct Syndrome |
4.3% |
| Pneumonia |
4.0% |
| Renal Failure |
4.0% |
| Diffuse Large B-cell Lymphoma |
2.9% |
| Maternal Drugs Affecting Foetus |
2.9% |
| Pancytopenia |
2.9% |
| Pregnancy |
2.9% |
| Renal Impairment |
2.9% |
| Rhabdomyolysis |
2.9% |
| Viral Load Increased |
2.9% |
| Lactic Acidosis |
2.7% |
|
| Concomitant |
| Hiv Infection |
62.4% |
| Drug Use For Unknown Indication |
8.8% |
| Product Used For Unknown Indication |
6.4% |
| Hypertension |
2.7% |
| Burkitt's Lymphoma |
2.6% |
| Antiretroviral Therapy |
2.2% |
| Pathogen Resistance |
1.8% |
| Prophylaxis |
1.6% |
| Antifungal Prophylaxis |
1.5% |
| Hepatitis C |
1.3% |
| Drug Exposure During Pregnancy |
1.3% |
| Hiv Test Positive |
1.2% |
| Depression |
1.1% |
| Systemic Antiviral Treatment |
0.9% |
| Drug Hypersensitivity |
0.7% |
| Insomnia |
0.7% |
| Pain |
0.7% |
| Necrotising Retinitis |
0.7% |
| Hodgkin's Disease |
0.7% |
| Asthma |
0.6% |
|
| Pyrexia |
10.6% |
| Weight Decreased |
9.6% |
| Vomiting |
7.4% |
| Pain |
6.4% |
| Weight Increased |
5.9% |
| Death |
5.3% |
| Coronary Artery Disease |
4.8% |
| Blood Creatinine Increased |
4.3% |
| Renal Failure Acute |
4.3% |
| Sepsis |
4.3% |
| Thrombocytopenia |
4.3% |
| Vaginal Haemorrhage |
4.3% |
| Haemolytic Anaemia |
3.7% |
| Liver Function Test Abnormal |
3.7% |
| Myocardial Infarction |
3.7% |
| Oesophageal Candidiasis |
3.7% |
| Rash Maculo-papular |
3.7% |
| Virologic Failure |
3.7% |
| Febrile Neutropenia |
3.2% |
| Renal Failure |
3.2% |
|
| Interacting |
| Hiv Infection |
33.8% |
| Antiretroviral Therapy |
20.9% |
| Drug Use For Unknown Indication |
9.0% |
| Product Used For Unknown Indication |
8.5% |
| Hypercholesterolaemia |
6.8% |
| Type 2 Diabetes Mellitus |
4.3% |
| Hypertension |
2.6% |
| Opportunistic Infection Prophylaxis |
2.1% |
| Urinary Tract Infection |
2.1% |
| Acne |
1.7% |
| Pain |
1.7% |
| Hyperlipidaemia |
1.3% |
| Hypertensive Heart Disease |
0.9% |
| Hypertensive Nephropathy |
0.9% |
| Lipodystrophy Acquired |
0.9% |
| Pain In Extremity |
0.9% |
| Adrenal Insufficiency |
0.4% |
| Bronchiectasis |
0.4% |
| Contraception |
0.4% |
| Diabetes Mellitus |
0.4% |
|
| Renal Failure Acute |
12.5% |
| Renal Tubular Disorder |
12.5% |
| Drug Interaction |
10.0% |
| Drug Resistance |
7.5% |
| Fanconi Syndrome |
7.5% |
| Renal Impairment |
7.5% |
| Rhabdomyolysis |
7.5% |
| Hypertriglyceridaemia |
5.0% |
| Hypokalaemia |
5.0% |
| Amenorrhoea |
2.5% |
| Anaemia |
2.5% |
| Blood Ph Decreased |
2.5% |
| Embolism Venous |
2.5% |
| Nephropathy Toxic |
2.5% |
| Pancreatitis Acute |
2.5% |
| Pregnancy With Implant Contraceptive |
2.5% |
| Secondary Adrenocortical Insufficiency |
2.5% |
| Tubulointerstitial Nephritis |
2.5% |
| Urine Analysis Abnormal |
2.5% |
|
